重症肌无力属自身免疫性疾病。在治疗上需根据个体差异给予抗胆碱酯酶剂。有时辅助采用肾上腺皮质激素、免疫抑制剂、免疫球蛋白,血浆交换疗法作为胸腺切除术前的辅助治疗。 胸腺切除术与重症肌无力的关系于1901年即有描述。自Saubruch于1912年报道1例肌无力患者在切除增大的胸腺后症状明显改善,从此胸腺切除术作为治疗重症肌无力的常用方法之一逐渐被采纳。 目前的争论之处在于手术的时机、入路的选择 Myasthenia gravis is an autoimmune disease. In the treatment according to individual differences to be given anticholinesterase agent. Sometimes assisted with adrenal cortex hormones, immunosuppressive agents, immunoglobulins, plasma exchange therapy as a pre-thymectomy adjuvant therapy. The relationship between thymectomy and myasthenia gravis was described in 1901. Since Saubruch reported in 1912 that one patient with myasthenia had significantly improved symptoms after removal of an enlarged thymus, thymectomy was gradually adopted as one of the common methods of treating myasthenia gravis. The current controversy lies in the timing of surgery, the choice of ways